Małgorzata Wichrowska

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Vascular Endothelial Growth Factor

Diabetic Retinopathy

Age Related Macular Degeneration

Top Venues

International journal of molecular sciences

Clinical ophthalmology (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Małgorzata Wichrowska, Przemysław Wichrowski, Jarosław Kocięcki
Morphological and Functional Assessment of the Optic Nerve Head and Retinal Ganglion Cells in Dry vs Chronically Treated Wet Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Małgorzata Wichrowska, Slawomir Liberski, Anna Rzeszotarska, Przemysław Wichrowski, Jarosław Kocięcki
Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes. International journal of molecular sciences 24 (1) (2022)
Małgorzata Wichrowska, Slawomir Liberski, Anna Rzeszotarska, Przemysław Wichrowski, Jarosław Kocięcki
Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes. International journal of molecular sciences 24 (1) (2022)
Małgorzata Wichrowska, Slawomir Liberski, Anna Rzeszotarska, Przemysław Wichrowski, Jarosław Kocięcki
Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes. International journal of molecular sciences 24 (1) (2022)
Slawomir Liberski, Małgorzata Wichrowska, Jarosław Kocięcki
Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review. International journal of molecular sciences 23 (16) (2022)
Małgorzata Wichrowska, Slawomir Liberski, Anna Rzeszotarska, Przemysław Wichrowski, Jarosław Kocięcki
Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes. International journal of molecular sciences 24 (1) (2022)